Patents Assigned to Pulmonx
  • Patent number: 11937913
    Abstract: A method for determining lung function in a patient is disclosed, in which a multi-lumen catheter with an expandable occluding element at its end is used to isolate a targeted lung compartment, and respiratory characteristics at the targeted lung compartment are measured over multiple respiratory cycles. The relation between various characteristics of the respiratory cycle is used to determine compliance of lung tissue within the targeted lung compartment.
    Type: Grant
    Filed: April 23, 2020
    Date of Patent: March 26, 2024
    Assignee: Pulmonx Corporation
    Inventors: Srikanth Radhakrishnan, Surag Mantri, Ryan Olivera
  • Patent number: 11931170
    Abstract: Lung conditions are diagnosed and optionally treated using a functional assessment catheter or a functional lung assessment and treatment catheter. A flow restrictive component is initially placed in a bronchus or lung passageway upstream from a diseased lung region. The isolated lung region is then functionally assessed through the catheter, while the flow restrictive component remains in place. If the patient is a good candidate for treatment by occlusive or restrictive treatment techniques, the flow resistive component may be left in place. If the patient is not suitable for such treatment, the flow resistive component may be removed.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: March 19, 2024
    Assignee: Pulmonx Corporation
    Inventors: Ajit Nair, Son Gia, Roger Farhnoltz, Nikolai Aljuri
  • Patent number: 11911145
    Abstract: Methods and systems for determining collateral ventilation are disclosed. Methods may comprise introducing a diagnostic catheter into a lung compartment via an assisted ventilation device, inflating the occluding member to isolate the lung compartment, and performing a diagnostic procedure with the catheter while the patient is ventilated via the assisted ventilation device. The diagnostic procedure comprises determining an exhaled volume from the isolated lung compartment over a predetermined period of time while the patient is ventilated via the assisted ventilation device. The presence collateral ventilation may be determined based on the exhaled volume from the isolated lung compartment over the predetermined period of time.
    Type: Grant
    Filed: June 30, 2021
    Date of Patent: February 27, 2024
    Assignee: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Publication number: 20240041362
    Abstract: Methods and systems for targeting, accessing and diagnosing diseased lung compartments are disclosed. The method comprises introducing a diagnostic catheter with an occluding member at its distal end into a lung segment via an assisted ventilation device; inflating the occluding member to isolate the lung segment; and performing a diagnostic procedure with the catheter while the patient is ventilated. The proximal end of the diagnostic catheter is configured to be attached to a console. The method may also comprise introducing the diagnostic catheter into the lung segment; inflating the occluding member to isolate the lung segment; and monitoring blood oxygen saturation. The method may further comprise introducing the diagnostic catheter into the lung segment; determining tidal flow volume in the lung segment; determining total lung capacity of the patient; and determining a flow rank value based on the tidal flow volume of the lung segment and the total lung capacity.
    Type: Application
    Filed: October 17, 2023
    Publication date: February 8, 2024
    Applicant: Pulmonx Corporation
    Inventors: Surag Mantri, Srikanth Radhakrishnan
  • Publication number: 20240032866
    Abstract: Devices systems and methods are disclosed for removing secretions from the lumen of a functional assessment catheter for the lungs. The system comprises a flushing unit configured to deliver a clearing fluid to the lumen of the pulmonary catheter to remove debris, secretions, or moisture from the lumen or sensors.
    Type: Application
    Filed: October 11, 2023
    Publication date: February 1, 2024
    Applicant: Pulmonx Corporation
    Inventor: Lutz FREITAG
  • Patent number: 11883029
    Abstract: The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment.
    Type: Grant
    Filed: July 19, 2022
    Date of Patent: January 30, 2024
    Assignee: Pulmonx Corporation
    Inventors: Nikolai Aljuri, Rodney C. Perkins, Niyazi Beyhan
  • Publication number: 20240008874
    Abstract: Devices, methods, and systems are provided for occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment. A video-assisted thoracoscopic device is inserted into a thoracic cavity of a patient and positioned at a fissure between a target lung compartment and an adjacent lung compartment. A collateral flow channel between the target lung compartment and the adjacent lung compartment is then identified using the video-assisted thoracoscopic device and an agent is injected into the collateral flow channel, thereby reducing the collateral flow channel.
    Type: Application
    Filed: June 8, 2023
    Publication date: January 11, 2024
    Applicant: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Patent number: 11857406
    Abstract: Disclosed are methods and devices for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and/or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and/or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region. An exemplary flow control device is configured to block fluid flow in the inspiratory direction and the expiratory direction at normal breathing pressures and allow fluid flow in the expiratory direction at higher than normal breathing pressures.
    Type: Grant
    Filed: November 15, 2022
    Date of Patent: January 2, 2024
    Assignee: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Patent number: 11819328
    Abstract: Methods and systems for targeting, accessing and diagnosing diseased lung compartments are disclosed. The method comprises introducing a diagnostic catheter with an occluding member at its distal end into a lung segment via an assisted ventilation device; inflating the occluding member to isolate the lung segment; and performing a diagnostic procedure with the catheter while the patient is ventilated. The proximal end of the diagnostic catheter is configured to be attached to a console. The method may also comprise introducing the diagnostic catheter into the lung segment; inflating the occluding member to isolate the lung segment; and monitoring blood oxygen saturation. The method may further comprise introducing the diagnostic catheter into the lung segment; determining tidal flow volume in the lung segment; determining total lung capacity of the patient; and determining a flow rank value based on the tidal flow volume of the lung segment and the total lung capacity.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: November 21, 2023
    Assignee: Pulmonx Corporation
    Inventors: Surag Mantri, Srikanth Radhakrishnan
  • Patent number: 11813085
    Abstract: Devices systems and methods are disclosed for removing secretions from the lumen of a functional assessment catheter for the lungs. The system comprises a flushing unit configured to deliver a clearing fluid to the lumen of the pulmonary catheter to remove debris, secretions, or moisture from the lumen or sensors.
    Type: Grant
    Filed: October 2, 2019
    Date of Patent: November 14, 2023
    Assignee: Pulmonx Corporation
    Inventor: Lutz Freitag
  • Patent number: 11696763
    Abstract: Devices, methods, and systems are provided for occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment. A video-assisted thoracoscopic device is inserted into a thoracic cavity of a patient and positioned at a fissure between a target lung compartment and an adjacent lung compartment. A collateral flow channel between the target lung compartment and the adjacent lung compartment is then identified using the video-assisted thoracoscopic device and an agent is injected into the collateral flow channel, thereby reducing the collateral flow channel.
    Type: Grant
    Filed: August 6, 2019
    Date of Patent: July 11, 2023
    Assignee: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Publication number: 20230136081
    Abstract: Disclosed are methods and devices for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and/or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and/or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region. An exemplary flow control device is configured to block fluid flow in the inspiratory direction and the expiratory direction at normal breathing pressures and allow fluid flow in the expiratory direction at higher than normal breathing pressures.
    Type: Application
    Filed: November 15, 2022
    Publication date: May 4, 2023
    Applicant: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Publication number: 20230000387
    Abstract: A method of diagnosing an air leak in a lung compartment of a patient may include: advancing a diagnostic catheter into an airway leading to the lung compartment; inflating an occluding member on the catheter to form a seal with a wall of the airway and thus isolate the lung compartment; measuring air pressure within the lung compartment during multiple breaths, using the diagnostic catheter; displaying the measured air pressure as an air pressure value on a console coupled with the diagnostic catheter; and determining whether an air leak is present in the lung compartment based on the displayed air pressure value during the multiple breaths.
    Type: Application
    Filed: September 8, 2022
    Publication date: January 5, 2023
    Applicant: Pulmonx Corporation
    Inventor: Surag MANTRI
  • Publication number: 20230000497
    Abstract: The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment.
    Type: Application
    Filed: July 19, 2022
    Publication date: January 5, 2023
    Applicant: Pulmonx Corporation
    Inventors: Nikolai Aljuri, Rodney C. Perkins, Niyazi Beyhan
  • Patent number: 11529224
    Abstract: Disclosed are methods and devices for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and/or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and/or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region. An exemplary flow control device is configured to block fluid flow in the inspiratory direction and the expiratory direction at normal breathing pressures and allow fluid flow in the expiratory direction at higher than normal breathing pressures.
    Type: Grant
    Filed: July 28, 2020
    Date of Patent: December 20, 2022
    Assignee: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Patent number: 11471069
    Abstract: A method of diagnosing an air leak in a lung compartment of a patient may include: advancing a diagnostic catheter into an airway leading to the lung compartment; inflating an occluding member on the catheter to form a seal with a wall of the airway and thus isolate the lung compartment; measuring air pressure within the lung compartment during multiple breaths, using the diagnostic catheter; displaying the measured air pressure as an air pressure value on a console coupled with the diagnostic catheter; and determining whether an air leak is present in the lung compartment based on the displayed air pressure value during the multiple breaths.
    Type: Grant
    Filed: April 11, 2022
    Date of Patent: October 18, 2022
    Assignee: Pulmonx Corporation
    Inventor: Surag Mantri
  • Patent number: 11413045
    Abstract: The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment.
    Type: Grant
    Filed: July 15, 2020
    Date of Patent: August 16, 2022
    Assignee: Pulmonx Corporation
    Inventors: Nikolai Aljuri, Rodney C. Perkins, Niyazi Beyhan
  • Publication number: 20220233095
    Abstract: A method of diagnosing an air leak in a lung compartment of a patient may include: advancing a diagnostic catheter into an airway leading to the lung compartment; inflating an occluding member on the catheter to form a seal with a wall of the airway and thus isolate the lung compartment; measuring air pressure within the lung compartment during multiple breaths, using the diagnostic catheter; displaying the measured air pressure as an air pressure value on a console coupled with the diagnostic catheter; and determining whether an air leak is present in the lung compartment based on the displayed air pressure value during the multiple breaths.
    Type: Application
    Filed: April 11, 2022
    Publication date: July 28, 2022
    Applicant: Pulmonx Corporation
    Inventor: Surag MANTRI
  • Publication number: 20220202467
    Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.
    Type: Application
    Filed: March 16, 2022
    Publication date: June 30, 2022
    Applicant: Pulmonx Corporation
    Inventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
  • Publication number: 20220184332
    Abstract: The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment. The invention further discloses a catheter with a transparent occlusion element at its tip that enables examination of the lung passageway through a viewing scope.
    Type: Application
    Filed: March 7, 2022
    Publication date: June 16, 2022
    Applicant: Pulmonx Corporation
    Inventors: Nikolai Aljuri, Rodney C. Perkins, Ryan Olivera, Hoang Nguyen, Srikanth Radhakrishnan, Niyazi Beyhan